Hans Narjes
Impact in
- Hepatology top 2%
- Hepatitis C virus research
- Infectious Diseases top 10%
- HIV/AIDS drug development and treatment
Papers in
-
- Inflammatory mediators and NSAID effects 7
- Pharmacogenetics and Drug Metabolism 3
- Oncology 5
- Drug Transport and Resistance Mechanisms 4
- Co-authors
- Günther Heinzel (9 shared papers)Ulrich W. Busch (7 shared papers)Gerhard Nehmiz (7 shared papers)Dominique Turck (6 shared papers)Mehdi Shahidi (1 shared paper)Kristell Marzin (1 shared paper)Dietmar Ganßer (1 shared paper)Thomas Ebner (1 shared paper)
- Journals
- British Journal of Clinical Pharmacology (4 papers)European Journal of Clinical Pharmacology (4 papers)The Journal of Clinical Pharmacology (2 papers)Inflammation Research (1 paper)Nature (1 paper)
- Partner nations
- GermanyUnited StatesCanada
In The Last Decade
Hans Narjes
17 papers receiving 1.1k citations
Hans Narjes's Hit Papers
Peers
Comparison fields: 5 of 88
- Hepatology 572
- Infectious Diseases 237
- Epidemiology 366
- Virology 46
- Pharmacology 153
Countries citing papers authored by Hans Narjes
This map shows the geographic impact of Hans Narjes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Narjes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Narjes more than expected).
Fields of papers citing papers by Hans Narjes
This network shows the impact of papers produced by Hans Narjes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Narjes. The network helps show where Hans Narjes may publish in the future.
Co-authors
The 21 scholars most cited alongside Hans Narjes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus Hit paper breakdown → | 2003 | 748 |
| 2 | 2011 | 118 | |
| 3 | 1997 | 70 | |
| 4 | Clinical pharmacokinetics of meloxicam. | 1997 | 66 |
| 5 | 1995 | 35 | |
| 6 | 1996 | 33 | |
| 7 | 1995 | 29 | |
| 8 | 1996 | 27 | |
| 9 | 2000 | 19 | |
| 10 | 1991 | 15 | |
| 11 | 1996 | 14 | |
| 12 | 2000 | 12 | |
| 13 | 2004 | 12 | |
| 14 | 1995 | 10 | |
| 15 | 1981 | 9 | |
| 16 | 1996 | 6 | |
| 17 | 1997 | 4 |
About Hans Narjes
Hans Narjes is a scholar working on Pharmacology, Pharmacology, Oncology, Cardiology and Cardiovascular Medicine and Internal Medicine, having authored 17 papers that have together received 1.2k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (7 papers), Drug Transport and Resistance Mechanisms (4 papers), Pharmacogenetics and Drug Metabolism (3 papers), Estrogen and related hormone effects (2 papers), Antiplatelet Therapy and Cardiovascular Diseases (2 papers), Statistical Methods in Clinical Trials (1 paper), Venous Thromboembolism Diagnosis and Management (1 paper) and Analytical Methods in Pharmaceuticals (1 paper). The work is most often cited by research in Hepatology (572 citations), Infectious Diseases (237 citations), Epidemiology (366 citations), Virology (46 citations) and Pharmacology (153 citations). Hans Narjes has collaborated with scholars based in Germany, United States and Canada. Frequent co-authors include Günther Heinzel, Ulrich W. Busch, Gerhard Nehmiz, Dominique Turck, Mehdi Shahidi, Kristell Marzin, Dietmar Ganßer, Thomas Ebner, Peter Stopfer and Thomas H. Müller. Their work appears in journals such as British Journal of Clinical Pharmacology, European Journal of Clinical Pharmacology, The Journal of Clinical Pharmacology, Inflammation Research and Nature.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.